Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated Jun 24, 2023, titled "Sun Pharma Presents Data from First-in-Human Phase 1 Studies of GL0034 at the American Diabetes Association 83rd Scientific Sessions".